{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:57:04Z","timestamp":1791100624192,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T00:00:00Z","timestamp":1267228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T00:00:00Z","timestamp":1267228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s15010-009-9148-6","type":"journal-article","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:11:53Z","timestamp":1267402313000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Inhaled Anti-infective Agents: Emphasis on Colistin"],"prefix":"10.1007","volume":"38","author":[{"given":"A.","family":"Michalopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,27]]},"reference":[{"key":"9148_CR1","first-page":"214","volume":"73","author":"J.E. Farber","year":"1950","unstructured":"Farber JE, Ross J: The use of aerosol penicillin and streptomycin in bronchopulmonary infection. Calif Med 1950; 73: 214\u2013217.","journal-title":"Calif Med"},{"key":"9148_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ppul.1950060207","volume":"6","author":"G. Steinkamp","year":"1989","unstructured":"Steinkamp G, T\u00fcmmler B, Gappa M, Albus A, Potel J, D\u00f6ring G, von der Hardt H: Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989; 6: 91\u201398.","journal-title":"Pediatr Pulmonol"},{"key":"9148_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ppul.1950070110","volume":"7","author":"I.B. MacLusky","year":"1989","unstructured":"MacLusky IB, Gold R, Corey M, Levison H: Long term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1989; 7: 42\u201348.","journal-title":"Pediatr Pulmonol"},{"key":"9148_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.0.CO;2-J","volume":"25","author":"H.G. Wiesemann","year":"1998","unstructured":"Wiesemann HG, Steinkamp G, Ratjen F, Bauernfeind A, Przyklenk B, D\u00f6ring G, von der Hardt H: Placebo controlled double blind randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr Pulmonol 1998; 25: 88\u201392.","journal-title":"Pediatr Pulmonol"},{"key":"9148_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJM199901073400104","volume":"340","author":"B.W. Ramsey","year":"1999","unstructured":"Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL: Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999; 340: 23\u201330.","journal-title":"N Engl J Med"},{"key":"9148_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(01)06124-4","volume":"358","author":"F. Ratjen","year":"2001","unstructured":"Ratjen F, D\u00f6ring G, Nikolaizik WH: Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonization in patients with cystic fibrosis. Lancet 2001; 358: 983\u2013984.","journal-title":"Lancet"},{"key":"9148_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1378\/chest.121.1.55","volume":"121","author":"R.B. Moss","year":"2002","unstructured":"Moss RB: Long term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest 2002; 121: 55\u201363.","journal-title":"Chest"},{"key":"9148_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1183\/09031936.02.00248102","volume":"20","author":"M.E. Hodson","year":"2002","unstructured":"Hodson ME, Gallagher CG, Govan JR: A randomized clinical trial of nebulized tobramycin or colistin in cystic fibrosis. Eur Respir J 2002; 20: 658\u2013664.","journal-title":"Eur Respir J"},{"key":"9148_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1164\/rccm.200208-855OC","volume":"167","author":"R.L. Gibson","year":"2003","unstructured":"Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B, Cystic Fibrosis Therapeutics Development Network Study Group: Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003; 167: 841\u2013849.","journal-title":"Am J Respir Crit Care Med"},{"key":"9148_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/sur.2006.051","volume":"8","author":"A. Hallal","year":"2007","unstructured":"Hallal A, Cohn SM, Namias N, Habib F, Baracco G, Manning RJ, Crookes B, Schulman CI: Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect (Larchmt) 2007; 8: 73\u201382.","journal-title":"Surg Infect (Larchmt)"},{"key":"9148_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ppul.10019","volume":"33","author":"B. Heinzl","year":"2002","unstructured":"Heinzl B, Eber E, Oberwaldner B, Haas G, Zach MS: Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study. Pediatr Pulmonol 2002; 33: 32\u201337.","journal-title":"Pediatr Pulmonol"},{"key":"9148_CR12","first-page":"79","volume":"7","author":"M. Griese","year":"2002","unstructured":"Griese M, Muller I, Reinhardt D: Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis. Eur J Med Res 2002; 7: 79\u201380.","journal-title":"Eur J Med Res"},{"key":"9148_CR13","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1097\/CCM.0b013e31817c0f9e","volume":"36","author":"L.B. Palmer","year":"2008","unstructured":"Palmer LB, Smaldone GC, Chen JJ, Baram D, Duan T, Monterforte M, Varela M, Tempone AK, O\u2019Riordan T, Darowalla F, Richman P: Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36: 2008\u20132013.","journal-title":"Crit Care Med"},{"key":"9148_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10096-008-0620-5","volume":"28","author":"D.E. Ghannam","year":"2009","unstructured":"Ghannam DE, Rodriguez GH, Raad II, Safdar A: Inhaled aminoglycosides in cancer patients with ventilator-associated Gramnegative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis 2009; 28: 253\u2013259.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9148_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1086\/429323","volume":"40","author":"M.E. Falagas","year":"2005","unstructured":"Falagas ME, Kasiakou SK: Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005; 40: 1333\u20131341.","journal-title":"Clin Infect Dis"},{"key":"9148_CR16","first-page":"557","volume":"35","author":"E. Katz","year":"1977","unstructured":"Katz E, Demain AL: The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions. Bacteriol Rev 1977; 35: 557\u2013564.","journal-title":"Bacteriol Rev"},{"key":"9148_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.bi.46.070177.003451","volume":"46","author":"D.R. Storm","year":"1977","unstructured":"Storm DR, Rosenthal KS, Swanson PE: Polymyxins and related peptide antibiotics. Annu Rev Biochem 1977; 46: 723\u2013763.","journal-title":"Annu Rev Biochem"},{"key":"9148_CR18","first-page":"125","volume":"29","author":"E.G. Beveridge","year":"1967","unstructured":"Beveridge EG, Martin AJ: Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol 1967; 29: 125\u2013135.","journal-title":"Br J Pharmacol"},{"key":"9148_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/jac\/39.2.255","volume":"39","author":"C.R. Catchpole","year":"1997","unstructured":"Catchpole CR, Andrews JM, Brenwald N, Wise R: A reassessment of the in vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 1997; 39: 255\u2013260.","journal-title":"J Antimicrob Chemother"},{"key":"9148_CR20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","volume":"43","author":"R.E. Hancock","year":"1999","unstructured":"Hancock RE, Chaple DS: Peptide antibiotics. Antimicrob Agents Chemother 1999; 43: 1317\u20131323.","journal-title":"Antimicrob Agents Chemother"},{"key":"9148_CR21","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1021\/bi00587a024","volume":"18","author":"M. Schindler","year":"1979","unstructured":"Schindler M, Osborn MJ: Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry 1979; 18: 4425\u20134430.","journal-title":"Biochemistry"},{"key":"9148_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/JCM.39.1.183-190.2001","volume":"39","author":"A.C. Galea","year":"2001","unstructured":"Galea AC, Reis AO, Jones RN: Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001; 39: 183\u2013190.","journal-title":"J Clin Microbiol"},{"key":"9148_CR23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/jac\/dkh470","volume":"54","author":"M. Hogardt","year":"2004","unstructured":"Hogardt M, Schmoldt S, Gotzfried M, Adler K, Heesemann J: Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 2004; 54: 1057\u20131061.","journal-title":"J Antimicrob Chemother"},{"key":"9148_CR24","volume-title":"Colomycin package insert information. Colomycin 1.000.000 IU vial\u2014colistin sulphomethate sodium","author":"Pharmax Ltd","year":"1998","unstructured":"Pharmax Ltd: Colomycin package insert information. Colomycin 1.000.000 IU vial\u2014colistin sulphomethate sodium. Pharmax Ltd, Bexley. 1998."},{"key":"9148_CR25","first-page":"2117","volume":"54","author":"G. Pino","year":"1963","unstructured":"Pino G, Conterno G, Colongo PG: Clinical observations on the activity of aerosol colimycin and of endobronchial instillations of colimycin in patients with pulmonary suppurations. Minerva Med 1963; 54: 2117\u20132122.","journal-title":"Minerva Med"},{"key":"9148_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0140-6736(91)91446-2","volume":"338","author":"N.H. Valerius","year":"1991","unstructured":"Valerius NH, Koch C, Hoiby N: Prevention of chronic Pseudomonas aeruginosa colonization in cystic fibrosis by early treatment. Lancet 1991; 338: 725\u2013726.","journal-title":"Lancet"},{"key":"9148_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jcf.2005.05.018","volume":"4","author":"N. Hoiby","year":"2005","unstructured":"Hoiby N, Frederiksen B, Pressler T: Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 2005; 4: 49\u201354.","journal-title":"J Cyst Fibros"},{"key":"9148_CR28","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/cc3020","volume":"9","author":"A. Michalopoulos","year":"2005","unstructured":"Michalopoulos A, Kasiakou S, Mastora Z, Rellos K, Kaposkekis M, Falagas ME: Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug resistant Gram-negativebacteria in patients without cystic fibrosis. Crit Care 2005; 9: R53\u2013R59.","journal-title":"Crit Care"},{"key":"9148_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1086\/432583","volume":"41","author":"A.L. Kwa","year":"2005","unstructured":"Kwa AL, Loh C, Low JJG, Kurup A, Tam VH: Nebulized colistin in the treatment of pneumonia due to multi drug resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2005; 41: 754\u2013757.","journal-title":"Clin Infect Dis"},{"key":"9148_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ajhp\/62.1.39","volume":"62","author":"D. Berlana","year":"2005","unstructured":"Berlana D, Llop JM, Fort E, Badia MB, Jodar R: Use of colistin in the treatment of multidrug-resistant Gram-negative infections. Am J Health Syst Pharm 2005; 62: 39\u201347.","journal-title":"Am J Health Syst Pharm"},{"key":"9148_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.rmed.2007.10.011","volume":"102","author":"A. Michalopoulos","year":"2008","unstructured":"Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME: Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Resp Med 2008; 102: 407\u2013412.","journal-title":"Resp Med"},{"key":"9148_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/jac\/dki461","volume":"57","author":"F. Ratzen","year":"2006","unstructured":"Ratzen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H, van Koningsbruggen S, Grasemann H: Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 2006; 57: 306\u2013311.","journal-title":"J Antimicrob Chemother"},{"key":"9148_CR33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-74-1-144","volume":"74","author":"G. Marschke","year":"1971","unstructured":"Marschke G, Sarauw A: Polymyxin inhalation therapeutic hazard. Ann Intern Med 1971; 74: 144\u2013145.","journal-title":"Ann Intern Med"},{"key":"9148_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.diagmicrobio.2007.01.008","volume":"58","author":"G.H. Pereira","year":"2007","unstructured":"Pereira GH, Muller PR, Levin AS: Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B. Diagn Microbiol Infect Dis 2007; 58: 235\u2013240.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9148_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ppul.20429","volume":"41","author":"R.L. Gibson","year":"2006","unstructured":"Gibson RL, Retsch-Bogart GZ, Oermann C, Milla C, Pilewski J, Dainew C, Ahrens R, Leon K, Cohen M, McNamara S, Callahan TL, Markus R, Burns JL: Microbiology, safety and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis. Pediatr Pumonol 2006; 41: 656\u2013665.","journal-title":"Pediatr Pumonol"},{"key":"9148_CR36","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/586739","volume":"46","author":"B.J. Rijnders","year":"2008","unstructured":"Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WC, Ruijgrok EJ, L\u00f6wenberg B, Vulto A, Lugtenburg PJ, de Marie S: Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis 2008; 46: 1401\u20131408.","journal-title":"Clin Infect Dis"},{"key":"9148_CR37","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1097\/01.TP.0000054233.60100.7A","volume":"75","author":"V. Monforte","year":"2003","unstructured":"Monforte V, Roman A, Gavalda J, Lopez R, Pou L, Simo M, Aguade S, Soriano B, Bravo C, Morell F: Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation 2003; 75: 1571\u20131574.","journal-title":"Transplantation"},{"key":"9148_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1517\/14740338.6.5.523","volume":"6","author":"S.A. Knechtel","year":"2007","unstructured":"Knechtel SA, Klepser ME: Safety of aerosolized amphotericin B. Expert Opin Drug Saf 2007; 6: 523\u2013532.","journal-title":"Expert Opin Drug Saf"},{"key":"9148_CR39","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJM199104183241602","volume":"324","author":"B. Hirschel","year":"1991","unstructured":"Hirschel B, Lazzaria A, Chopard P, Opravil M, Furrer HJ, Ruttimann S, Vernazza P, Chave JP, Ancarani V: A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii. N Engl J Med 1991; 324: 1079\u20131083.","journal-title":"N Engl J Med"},{"key":"9148_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199503163321101","volume":"332","author":"S.A. Bozzette","year":"1995","unstructured":"Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly W, He W, Phillips L, Craven D, Van der Horst C, Feinberg J: A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection: NIAID AIDS Clinical Trials Group. N Engl J Med 1995; 332: 693\u2013699.","journal-title":"N Engl J Med"},{"key":"9148_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1034\/j.1399-3062.2002.t01-1-00008.x","volume":"4","author":"T.K. Marras","year":"2002","unstructured":"Marras TK, Sanders K, Lipton JH, Messner HA, Conly J, Chan CK: Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation. Transpl Infect Dis 2002; 4: 66\u201374.","journal-title":"Transpl Infect Dis"},{"key":"9148_CR42","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1378\/chest.108.4.946","volume":"108","author":"M.L. Metersky","year":"1995","unstructured":"Metersky ML, Colt HG, Olson LK, Shanks TG: AIDS related spontaneous pneumothorax. Risk factors and treatment. Chest 1995; 108: 946\u2013951.","journal-title":"Chest"},{"key":"9148_CR43","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/jama.268.10.1280","volume":"268","author":"C. Beck-Sague","year":"1992","unstructured":"Beck-Sague C, Dooley SW, Hutton MD, Otten G, Breeden A, Crawford JT, Pitchenik AE, Woodley C, Cauthen G, Jarvis WR: Hospital outbreak of multidrug resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV infected patients. JAMA 1992; 268: 1280\u20131286.","journal-title":"JAMA"},{"key":"9148_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ppul.20736","volume":"43","author":"G.Z. Retsch-Bogart","year":"2008","unstructured":"Retsch-Bogart GZ, Burns JL, Otto KL, Liou TG, McCoy K, Oermann C, Gibson RL, AZLI Phase II Study Group: A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol 2008; 43: 47\u201358.","journal-title":"Pediatr Pulmonol"},{"key":"9148_CR45","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1055\/s-2004-815667","volume":"24","author":"W.P. Sexauer","year":"2003","unstructured":"Sexauer WP, Fiel SB: Aerosolized antibiotics in cystic fibrosis. Semin Respir Crit Care Med 2003; 24: 717\u2013726.","journal-title":"Semin Respir Crit Care Med"},{"key":"9148_CR46","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1378\/chest.127.2.522","volume":"127","author":"G. Alothman","year":"2005","unstructured":"Alothman G, Ho B, Alsaadi MM, Ho SL, O\u2019Drowsky L, Allen EL, Coates L: Bronchial constriction and inhaled colistin in cystic fibrosis. Chest 2005; 127: 522\u2013529.","journal-title":"Chest"},{"key":"9148_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0195-6701(03)00263-9","volume":"55","author":"C. Schultsz","year":"2003","unstructured":"Schultsz C, Meester HH, Kranenberg AM, Savelkoul PH, Boejen-Donkers LE, Kaiser AM, deBree R, Snow GB, Vanderbroucke-Grauls CJ: Ultrasonic nebulizers as a potential source of methicillin resistant Staphylococcus aureus causing an outbreak in a university tertiary care hospital. J Hosp Infect 2003; 55: 269\u2013275.","journal-title":"J Hosp Infect"},{"key":"9148_CR48","first-page":"761","volume":"132","author":"P.M. Mendelman","year":"1985","unstructured":"Mendelman PM, Smith AL, Levy J: Aminoglycoside penetration, inactivation and efficacy in cystic fibrosis sputum. Am Rev Respir Dis 1985; 132: 761\u2013765.","journal-title":"Am Rev Respir Dis"},{"key":"9148_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/17425247.4.2.91","volume":"4","author":"E.M. Westerman","year":"2007","unstructured":"Westerman EM, Heijerman HGM, Frijlink HW: Dry powder inhalation versus nebulisation delivery of antibiotics in cystic fibrosis patients. Expert Opin Drug Deliv 2007; 4: 91\u201394.","journal-title":"Expert Opin Drug Deliv"},{"key":"9148_CR50","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1378\/chest.111.4.955","volume":"111","author":"J. Eisenberg","year":"1997","unstructured":"Eisenberg J, Pepe M, Williams-Warren JA, Aerosolized Tobramycin Study Group: Comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Chest 1997; 111: 955\u2013963.","journal-title":"Chest"},{"key":"9148_CR51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ppul.20594","volume":"42","author":"D.E. Geller","year":"2007","unstructured":"Geller DE, Konstan MW, Smith J, Noonberg SB, Conrad C: Novel tobramycin inhalation powdering cystic fibrosis subjects: pharmacokinetics and safety. Pediatr Pulmonol 2007; 42: 307\u2013313.","journal-title":"Pediatr Pulmonol"},{"key":"9148_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1517\/17425247.3.1.71","volume":"3","author":"J.K. Hagerman","year":"2006","unstructured":"Hagerman JK, Hancock KE, Klepser ME: Aerosolised antibiotics: a critical appraisal of their use. Expert Opin Drug Deliv 2006; 3: 71\u201386.","journal-title":"Expert Opin Drug Deliv"},{"key":"9148_CR53","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1164\/ajrccm.160.5.9810080","volume":"160","author":"N.R. Crowther Labiris","year":"1999","unstructured":"Crowther Labiris NR, Holbrook AM, Chrystyn H, Macleod SM, Newhouse MT: Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Am J Respir Crit Care Med 1999; 160: 1711\u20131716.","journal-title":"Am J Respir Crit Care Med"},{"key":"9148_CR54","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1586\/17476348.2.4.479","volume":"2","author":"S.B. Fiel","year":"2008","unstructured":"Fiel SB: Aerosolized antibiotics in cystic fibrosis: current and future trends. Expert Rev Respir Med 2008; 2: 479\u2013487.","journal-title":"Expert Rev Respir Med"},{"key":"9148_CR55","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1183\/09031936.95.08091594","volume":"8","author":"D.J. Touw","year":"1995","unstructured":"Touw DJ, Brimicombe RW, Hodson ME, Heijerman HG, Bakker W: Inhalation of antibiotics in cystic fibrosis. Eur Respir J 1995; 8: 1594\u20131604.","journal-title":"Eur Respir J"},{"key":"9148_CR56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.41.1.184","volume":"41","author":"D.J. Touw","year":"1997","unstructured":"Touw DJ, Jacobs FA, Brimicombe RW: Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis. Antimicrob Agents Chemother 1997; 41: 184\u2013187.","journal-title":"Antimicrob Agents Chemother"},{"key":"9148_CR57","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1378\/chest.120.3_suppl.118S","volume":"120","author":"J.J. LiPuma","year":"2001","unstructured":"LiPuma JJ: Microbiological and immunologic considerations with aerosolized drug delivery. Chest 2001; 120 (3 Suppl): S118\u2013S123.","journal-title":"Chest"},{"key":"9148_CR58","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/jac\/dkm385","volume":"60","author":"E. Ioannidou","year":"2007","unstructured":"Ioannidou E, Siempos II, Falagas ME: Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother 2007; 60: 1216\u20131226.","journal-title":"J Antimicrob Chemother"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-009-9148-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-009-9148-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-009-9148-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-009-9148-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:24:34Z","timestamp":1744169074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-009-9148-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,27]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["9148"],"URL":"https:\/\/doi.org\/10.1007\/s15010-009-9148-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,27]]},"assertion":[{"value":"10 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}